U.S. Blood-based Biomaker For Sports Medicine Market Size & Outlook
U.S. blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
U.S. blood-based biomaker for sports medicine market highlights
- The U.S. blood-based biomaker for sports medicine market generated a revenue of USD 240.1 million in 2023 and is expected to reach USD 425.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 240.1 million |
| Market revenue in 2030 | USD 425.8 million |
| Growth rate | 8.5% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, U.S. accounted for 36.1% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 425.8 million by 2030.
Ck was the largest segment with a revenue share of 17.99% in 2023. Horizon Databook has segmented the U.S. blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
Sports participation in the U.S. is on the rise, leading to an increase in sports-related injuries. This trend is expected to facilitate significant growth in the U.S. blood-based biomarkers for sports medicine market. These biomarkers offer a noninvasive, precise method for diagnosing & managing injuries, allowing for more effective treatment and faster recovery times.
As athletes and healthcare providers increasingly prioritize injury prevention & recovery, the demand for advanced biomarker technologies is anticipated to grow. A study by Johns Hopkins Medicine reports that in the U.S., around 30 million children and teens engage in organized sports, with over 3.5 million sustaining injuries annually.
In addition, around 8.6 million people aged 5 and older injure themselves annually while participating in sports. This growth is supported by ongoing R&D & collaborations between medical institutions and industry leaders.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
U.S. Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
